Entera Bio (ENTX) Net Equity Issued and Repurchased (2021 - 2025)
Entera Bio (ENTX) posted quarterly Net Equity Issued and Repurchased of $71000.0 for Q3 2025, down 98.85% on a QoQ basis from $6.2 million in Q1 2025.
Entera Bio (ENTX) Net Equity Issued and Repurchased (2021 - 2025) Analysis & Trends
Entera Bio (ENTX) has reported Net Equity Issued and Repurchased for 3 consecutive years, with $71000.0 the latest figure, recorded in Q3 2025.
- Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $71000.0 in Q3 2025, while the trailing twelve-month figure through Mar 2026 was $71000.0 (down 99.3% YoY) and the FY2025 annual result came in at $6.3 million, up 57.93% from the prior year.
- Net Equity Issued and Repurchased eased to $71000.0 in Q3 2025 per ENTX's latest filing, from $6.2 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for ENTX reached as high as $9.9 million in Q1 2021 and fell as low as $71000.0 in Q3 2025.
- A 3-year average of $4.6 million and a median of $3.3 million in 2024 frame the typical range for Net Equity Issued and Repurchased.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | Entera Bio | 186.78 Mn | 182.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 71,000.00 |
| Sep 30, 2025 | 71,000.00 |
| Mar 31, 2025 | 6.18 Mn |
| Mar 31, 2025 | 6.18 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Dec 31, 2024 | 3.34 Mn |
| Jun 30, 2024 | 620,000.00 |
| Jun 30, 2024 | 620,000.00 |
| Sep 30, 2021 | 2.46 Mn |
| Sep 30, 2021 | 2.46 Mn |
| Jun 30, 2021 | 9.48 Mn |
| Jun 30, 2021 | 9.48 Mn |
| Mar 31, 2021 | 9.86 Mn |
| Mar 31, 2021 | 9.86 Mn |